Eminase

BACKGROUND QT dispersion (QTd; QT interval maximum minus minimum) has been shown to reflect regional variations in ventricular… (More)

The outcome of patients with Thrombolysis in Myocardial Infarction (TIMI) trial grade 2 flow is worse than that of patients with… (More)

BACKGROUND A double-blind, placebo-controlled study using anistreplase was performed in 159 patients with unstable angina. All… (More)

Smokers have been reported to have an improved short-term prognosis after myocardial infarction when compared with nonsmokers… (More)

One measure of the success of thrombolysis is the early patency status of the infarct-related coronary artery. The Thrombolysis… (More)

Several production lots of Anistreplase (Eminase) were assayed for potency by either two fibrin plate assays or a clot lysis… (More)

Eminase (anistreplase), or anisoylated plasminogen streptokinase activator complex (APSAC), is a reversibly inactivated lys… (More)

Coronary recanalisation rate is one of the parameters utilized to evaluate the effectiveness of a thrombolytic agent. This… (More)

Too few myocardial infarctions are thrombolysed, and the thrombolytic agent is usually administered too late. This situation can… (More)

Tissue Plasminogen Activator (t-PA), Single Chain Urokinase Plasminogen Activator or pro-Urokinase (scu-PA or pro-UK) and acyl… (More)